市场调查报告书
商品编码
1468391
2024-2032 年按服务(手术、诊断测试和影像、身体健康监测等)、动物类型(伴侣动物、农场动物)、最终用途(兽医诊所、兽医医院)和地区分類的兽医服务市场报告Veterinary Service Market Report by Service (Surgery, Diagnostic Tests and Imaging, Physical Health Monitoring, and Others), Animal Type (Companion Animal, Farm Animal), End Use (Veterinary Clinic, Veterinary Hospital), and Region 2024-2032 |
2023年全球兽医服务市场规模达1,131亿IMARC Group。
兽医服务用于动物疾病、人畜共患病和食源性人畜共患病的监测、早期诊断和治疗。它依靠兽药产品(例如抗菌剂)来最大限度地减少动物源性食品中兽药残留和抗菌素抗药性(AMR)产生的不合规可能性。除此之外,它还有助于提高人们对食品生产商、加工商和分销商的认识,并解决动物生产食品安全问题。
随着源自动物的人类病原体数量不断增加,兽医服务对于保护动物、保障公众健康和确保食品安全变得越来越重要。这与世界各地越来越多地采用伴侣动物结合,是刺激市场成长的关键因素之一。此外,由于冠状病毒病(COVID-19)的爆发,许多国家的政府正在放宽远距医疗和兽医-客户-患者关係(VCPR)法规,并向宠物父母提供远距医疗。它在兽医中用于术后检查、皮肤病学问题、行为问题以及对患有慢性疾病的宠物进行定期随访,从而允许兽医在不直接检查宠物的情况下开出治疗处方。再加上最近宠物服务的扩张,包括线上宠物药局以及透过订阅服务提供食品和产品,正在推动市场成长。除此之外,动物健康生物技术的进步,如疫苗、抗菌药物和诊断工具,可最大限度地减少疾病负担并提高动物健康和福利标准,正在对市场产生积极影响。此外,预计畜牧业的显着增长将为未来几年的市场创造积极的前景。
The global veterinary service market size reached US$ 113.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 170.0 Billion by 2032, exhibiting a growth rate (CAGR) of 4.5% during 2024-2032.
A veterinary service is utilized in the surveillance, early diagnosis, and treatment of animal diseases, zoonoses, and foodborne zoonotic hazards. It relies on veterinary medicinal products, such as antimicrobial agents, to minimize the likelihood of non-compliance concerning veterinary drug residues in food of animal origin and the development of antimicrobial resistance (AMR). Besides this, it assists in increasing awareness about food producers, processors and distributors, and addressing animal production food safety.
With the rising number of human pathogens originating in animals, veterinary services are presently becoming increasingly essential for protecting animals, safeguarding public health, and ensuring food safety. This, in confluence with the increasing adoption of companion animals around the world, represents one of the key factors stimulating the growth of the market. Moreover, governments of numerous countries are relaxing the telemedicine and veterinarian-client-patient relationship (VCPR) regulations on account of the coronavirus disease (COVID-19) outbreak and making telemedicine available to pet parents. It is utilized in veterinary for postoperative checks, dermatologic concerns, behavioral issues, and scheduled follow-up visits for pets with chronic diseases, thereby allowing veterinarians to prescribe the treatment without the direct examination of pets. This, coupled with recent expansions in pet services, including online pet pharmacies and food and product delivery via subscription services, is impelling the market growth. Apart from this, advances in animal health biotechnologies, such as vaccines, antimicrobials, and diagnostic tools, for minimizing the burden of diseases and improving the standards of animal health and welfare are positively influencing the market. In addition, significant growth in the livestock sector is projected to create a positive outlook for the market in the upcoming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary service market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on service, animal type, and end use.
Surgery
Diagnostic Tests and Imaging
Physical Health Monitoring
Others
Companion Animal
Farm Animal
Veterinary Clinic
Veterinary Hospital
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Addison Biological Laboratory Inc., Armor Animal Health, CityVet, CVS Group PLC, Elanco Animal Health Incorporated, Ethos Veterinary Health LLC, FirstVet, Greencross Vets, Heska Corporation, Idexx Laboratories Inc., Intervet Inc. (Merck & Co. Inc.), PetIQ LLC and Pets at Home Group PLC.